Mitochondrial-Encoded Immunity in Aging

衰老中的线粒体编码免疫

基本信息

  • 批准号:
    10688318
  • 负责人:
  • 金额:
    $ 33.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Aging is associated with a loss of immune function (immunosenescence) and chronic low-grade inflammation (inflammaging). However, the mechanistic details of our aging immunity are largely enigmatic. Metabolism and immunity have co-evolved, and metabolic pathways are increasingly appreciated as key regulators of our immune system. Mitochondria, being the most important metabolic organelle, have also gained much attention as regulatory hubs of various immune functions. Owing to their bacterial ancestry, mitochondria possess their own genome. While mtDNA itself can trigger immune responses and directly entrap pathogens, it is not known to encode for immune factors. Currently, our immunity is known to be nuclear-encoded. We have recently identified a novel gene encoded within the mitochondrial DNA and named it MOTS-c (Mitochondrial ORF within the Twelve S rRNA). MOTS-c is an age-dependent peptide that regulates metabolic homeostasis and significantly improves aging metabolism and physical fitness in mice. Here, we describe MOTS-c as the first-in-class mitochondrial-encoded immune factor that acts as an antimicrobial peptide (AMP). MOTS-c, consistent with other AMPs, is expressed by various cells including monocytes and macrophages. The identification of MOTS-c was strongly influenced by prior work from the laboratory of Sidney Pestka (aka “father of interferon”), whereby the great majority of mRNAs induced by interferon were from the mitochondrial 12S rRNA in monocyte-like cells (no genes were identified at that time). Indeed, we now demonstrate that MOTS-c peptide expression is induced by interferon gamma. AMPs also regulate immune cell functions, including monocytes/macrophages. This is consistent with our preliminary data whereby MOTS-c moves to the nucleus to program monocyte differentiation to generate unique macrophages that are characterized by increased expression of interferon-stimulated genes (ISGs) and antigen presentation genes. Such “MOTS-c-programmed” macrophages had increased bactericidal capacity. This observation builds on our recent report on MOTS-c as the first-in-class mitochondrial-encoded factor that translocates to the nucleus and directly regulates stress-adaptive nuclear gene expression. Here, we propose to test the hypothesis that MOTS-c is an age-dependent and IFN-inducible mitochondrial- encoded AMP, a first-in-class, that programs monocytes to differentiate into unique IFN-poised macrophages with enhanced bactericidal capacity. We propose three aims to test this hypothesis: (1) Determine whether MOTS-c- programmed macrophages are epigenetically “IFN-poised” for enhanced antibacterial responses, (2) Test whether metabolic rewiring enhances bactericidal capacity of MOTS-c-programmed macrophages, and (3) Determine the functional effect of MOTS-c on monocytes and BMDMs during aging in mice. If successful, we predict that our study will have broad and lasting impact including (i) the first identification of a mitochondrial-encoded AMP and (ii) the identification of novel mitochondrial-centric drug class that can restore macrophage function during aging; the mitochondrial genome has yet to be mined for FDA-approved therapeutics.
摘要 衰老与免疫功能丧失(免疫衰老)和慢性低度炎症有关 (发炎)。然而,我们衰老免疫力的机制细节在很大程度上是谜。代谢和 免疫系统已经共同进化,代谢途径越来越被认为是我们免疫系统的关键调节因子。 系统线粒体作为最重要的代谢细胞器, 各种免疫功能的枢纽。由于它们的细菌祖先,线粒体拥有自己的基因组。 虽然线粒体DNA本身可以引发免疫反应并直接捕获病原体,但尚不清楚它是否编码 免疫因素目前,我们的免疫力被认为是核编码的。我们最近发现了一种新的基因 在线粒体DNA中编码,并将其命名为MOTS-c(十二S rRNA内的线粒体ORF)。 MOTS-c是一种年龄依赖性肽,可调节代谢稳态,显著改善衰老 代谢和身体健康。 在这里,我们将MOTS-c描述为第一种由尿道编码的免疫因子, 肽(AMP)。MOTS-c与其他AMP一致,由各种细胞表达,包括单核细胞和巨噬细胞。 巨噬细胞MOTS-c的鉴定受到Sidney实验室先前工作的强烈影响 Pestka(又称“干扰素之父”),其中绝大多数由干扰素诱导的mRNAs来自 在单核细胞样细胞中的线粒体12 S rRNA(当时未鉴定出基因)。事实上,我们现在证明, MOTS-c肽的表达是由干扰素γ诱导的。AMP还调节免疫细胞功能, 包括单核细胞/巨噬细胞。这与我们的初步数据一致,其中MOTS-c移动到 核编程单核细胞分化,以产生独特的巨噬细胞,其特征在于增加 干扰素刺激基因(ISG)和抗原呈递基因的表达。这种“MOTS-c-programmed” 巨噬细胞的杀菌能力增强。这一意见是基于我们最近关于MOTS-c的报告, 第一个转位到细胞核并直接调节压力适应的神经编码因子 核基因表达 在这里,我们建议测试MOTS-c是一种年龄依赖性和IFN诱导的线粒体- 编码的AMP,一流的,编程单核细胞分化成独特的IFN-平衡的巨噬细胞, 增强杀菌能力。我们提出了三个目标来检验这一假设:(1)确定MOTS-c- 程序化巨噬细胞在表观遗传学上是“IFN-平衡”的,用于增强抗菌反应,(2)测试是否 代谢重新布线增强MOTS-c程序化巨噬细胞的杀菌能力,和(3)确定 MOTS-c在小鼠衰老过程中对单核细胞和BMDM的功能作用。如果成功,我们预测我们的研究 将产生广泛而持久的影响,包括(i)首次识别出密码编码的AMP,以及(ii) 鉴定可在衰老过程中恢复巨噬细胞功能的新的以肾脏为中心的药物类别; 线粒体基因组尚未被开发用于FDA批准的疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Changhan Lee其他文献

Changhan Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Changhan Lee', 18)}}的其他基金

Mitochondrial-Encoded Regulators of the Nucleus and Cellular Homeostasis
线粒体编码的细胞核和细胞稳态调节因子
  • 批准号:
    10665790
  • 财政年份:
    2022
  • 资助金额:
    $ 33.83万
  • 项目类别:
Mitochondrial-Encoded Regulators of the Nucleus and Cellular Homeostasis
线粒体编码的细胞核和细胞稳态调节因子
  • 批准号:
    10527988
  • 财政年份:
    2022
  • 资助金额:
    $ 33.83万
  • 项目类别:
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors
新型线粒体编码肿瘤抑制剂对细胞增殖的调节
  • 批准号:
    10408149
  • 财政年份:
    2020
  • 资助金额:
    $ 33.83万
  • 项目类别:
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors
新型线粒体编码肿瘤抑制剂对细胞增殖的调节
  • 批准号:
    10625424
  • 财政年份:
    2020
  • 资助金额:
    $ 33.83万
  • 项目类别:
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors
新型线粒体编码肿瘤抑制剂对细胞增殖的调节
  • 批准号:
    10238768
  • 财政年份:
    2020
  • 资助金额:
    $ 33.83万
  • 项目类别:
Regulation of Cellular Proliferation by Novel Mitochondrial-Encoded Tumor Suppressors
新型线粒体编码肿瘤抑制剂对细胞增殖的调节
  • 批准号:
    10389994
  • 财政年份:
    2020
  • 资助金额:
    $ 33.83万
  • 项目类别:
Novel Regulators of Aging Metabolism Encoded in the Mitochondrial Genome
线粒体基因组编码的衰老代谢的新型调节因子
  • 批准号:
    9082507
  • 财政年份:
    2016
  • 资助金额:
    $ 33.83万
  • 项目类别:
Novel Regulators of Aging Metabolism Encoded in the Mitochondrial Genome
线粒体基因组编码的衰老代谢的新型调节因子
  • 批准号:
    9923533
  • 财政年份:
    2016
  • 资助金额:
    $ 33.83万
  • 项目类别:
Novel Regulators of Aging Metabolism Encoded in the Mitochondrial Genome
线粒体基因组编码的衰老代谢的新型调节因子
  • 批准号:
    9932647
  • 财政年份:
    2016
  • 资助金额:
    $ 33.83万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 33.83万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了